Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients

Clinical trial NCT00707954 · COMPLETED

Trial details

NCT number: NCT00707954
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2008-06-01
Primary completion: 2009-02-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.